US News

Pfizer oral COVID-19 pill gets U.S. authorization for at-home use

Published by
Reuters

(Reuters) -Pfizer Inc said on Wednesday the U.S. Food and Drug Administration authorized its antiviral COVID-19 pill, making it the first at-home treatment for the coronavirus that is expected to become an important tool in the fight against the fast spreading Omicron variant. Data from Pfizer’s clinical trial showed its antiviral regimen was 90% effective in preventing hospitalizations and deaths in patients at high risk of severe illness. Recent lab data suggests the drug retains its effectiveness against Omicron. The agency said it authorized the oral drug for emergency use for the treatmen…

Read More

Facebook Comments

Check Also

States Investigating Surge In Mortality Rate Among 18–49-Year-Olds, Majority Unrelated To COVID-19

States Investigating Surge In Mortality Rate Among 18–49-Year-Olds, ...

Archives